Intellicell Biosciences Inc (fka SVFC)

[Traderboy1966]

Clinical Studies
To increase the value of its business model, IntelliCell is in the process of
selectively making investments to launch clinical trials so that in the future it can
make clinical claims for its cellular product. These clinical studies will be IND/IRB
FDA studies to achieve FDA approval for clinical claims. Areas under
consideration include
• Treating osteoarthritis of the knee
• Gingival gum regeneration, both of which have demonstrated safety and
efficacy in published early pre-clinical work
• Wound healing to treat non-healing diabetic ulcers
• Future product candidates include:
o Multiple sclerosis
o Erectile dysfunction
o General dermal regeneration
One of the major advantages of conducting these clinical studies is that since the
SVFC's are already used by Regen Medical PC to treat patients, the outcome of 4
the effectiveness of the treatment is already known. This is a significant
difference over traditional pharmaceutical trials where the outcome of the clinical
trial is usually not well known.